AML, or acute myelogenous leukemia, is cancer affecting the blood and bone marrow. The bone marrow is where blood cells are produced in the spongy tissue inside bones.
The term “acute” in AML refers to the rapid progression of the disease. It is called myelogenous leukemia because it affects a specific group of white blood cells called myeloid cells. These cells typically develop into various mature blood cells, including red blood cells, white blood cells, and platelets.
AML is also known as acute myeloid leukemia, acute myeloblastic leukemia, acute granulocytic leukemia, and acute nonlymphocytic leukemia.